5.02
price up icon1.21%   0.07
after-market Handel nachbörslich: 5.04 0.02 +0.40%
loading

Mannkind Corp Aktie (MNKD) Neueste Nachrichten

pulisher
Mar 21, 2025

Cantor maintains Overweight rating on MannKind stock at $9 target - Investing.com

Mar 21, 2025
pulisher
Mar 19, 2025

Why It's Worth Keeping An Eye On MannKind - RTTNews

Mar 19, 2025
pulisher
Mar 18, 2025

Inhalable Biologics Industry Report 2025: World Market to Nearly Triple in Size by 2030, Reaching $10.06 Billion at a CAGR of 17.6% - Yahoo Finance

Mar 18, 2025
pulisher
Mar 12, 2025

MannKind at Barclays Healthcare Conference: Strategic Growth and Innovation - Investing.com India

Mar 12, 2025
pulisher
Mar 11, 2025

MAC Lung Disease Market Statistics Expected to Experience Major - openPR

Mar 11, 2025
pulisher
Mar 10, 2025

MannKind Corporation Showcases Positive Outcomes of Inhaled Insulin at ATTD 2025 with Anticipated sNDA Filing for Pediatric Use in 2025 - Nasdaq

Mar 10, 2025
pulisher
Mar 10, 2025

MannKind Showcases Efficacy, Safety, and Mealtime Control Data from Recent Pediatric and Adult Studies of Afrezza® at the ATTD Conference, March 19-22 - Yahoo Finance

Mar 10, 2025
pulisher
Mar 07, 2025

AllPennyStocks.com News: Companies Looking Towards Future Revenue with New Diabetes Therapies - ACCESS Newswire

Mar 07, 2025
pulisher
Mar 07, 2025

Commit To Purchase MannKind At $3, Earn 13.3% Using Options - Nasdaq

Mar 07, 2025
pulisher
Mar 04, 2025

Non- Tuberculous Mycobacterial Infections Market on Track for Major Expansion by 2034, According to DelveInsight | Insmed, AN2 Therapeutics, Mannkind Corp., Spero Therapeutics, Savara Pharma - Barchart

Mar 04, 2025
pulisher
Mar 04, 2025

Non- Tuberculous Mycobacterial Infections Market on Track - openPR

Mar 04, 2025
pulisher
Mar 02, 2025

MannKind Stock Surges After-Hours On Q4 Revenue Beat, Debt Reduction As Retail Investors Celebrate ‘Amazing Comeback’ - MSN

Mar 02, 2025
pulisher
Mar 01, 2025

MannKind Corporation Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now - Yahoo Finance

Mar 01, 2025
pulisher
Feb 28, 2025

MannKind Full Year 2024 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance

Feb 28, 2025
pulisher
Feb 28, 2025

Decoding MannKind Corp (MNKD): A Strategic SWOT Insight - GuruFocus.com

Feb 28, 2025
pulisher
Feb 27, 2025

MannKind Q4 Review: Solid Financials, But Tyvaso DPI's Market Share In Question - Seeking Alpha

Feb 27, 2025
pulisher
Feb 27, 2025

MannKind Corporation (NASDAQ:MNKD) Q4 2024 Earnings Call Transcript - Insider Monkey

Feb 27, 2025
pulisher
Feb 27, 2025

MannKind: Q4 Earnings Snapshot - mySA

Feb 27, 2025
pulisher
Feb 27, 2025

MannKind Corp (MNKD) Q4 2024 Earnings Call Highlights: Record Re - GuruFocus.com

Feb 27, 2025
pulisher
Feb 27, 2025

MannKind Corp Q4 Earnings: EPS Meets Estimates at $0.03, Revenue Surpasses Expectations at $77 Million - GuruFocus.com

Feb 27, 2025
pulisher
Feb 27, 2025

MannKind Corp (MNKD) Q4 2024 Earnings Call Highlights: Record Revenue Growth and Strategic ... - Yahoo Finance

Feb 27, 2025
pulisher
Feb 26, 2025

Mannkind stock gains amid Q4 report, business update - MSN

Feb 26, 2025
pulisher
Feb 26, 2025

MannKind Corp reports results for the quarter ended December 31Earnings Summary - TradingView

Feb 26, 2025
pulisher
Feb 26, 2025

MannKind (MNKD) Q4 Earnings Meet Estimates - Yahoo Finance

Feb 26, 2025
pulisher
Feb 26, 2025

Earnings call transcript: MannKind Q4 2024 beats EPS forecast, stock jumps - Investing.com

Feb 26, 2025
pulisher
Feb 26, 2025

MannKind earnings beat by $0.05, revenue topped estimates - Investing.com

Feb 26, 2025
pulisher
Feb 26, 2025

MannKind shares move 4% higher on strong revenue growth By Investing.com - Investing.com South Africa

Feb 26, 2025
pulisher
Feb 26, 2025

MannKind shares move 4% higher on strong revenue growth - Investing.com

Feb 26, 2025
pulisher
Feb 26, 2025

MANNKIND CORP SEC 10-K Report - TradingView

Feb 26, 2025
pulisher
Feb 25, 2025

MannKind Corp (MNKD) Q4 2024 Earnings Report Preview: What To Expect - Yahoo Finance

Feb 25, 2025
pulisher
Feb 24, 2025

Exploring Three High Growth Tech Stocks in the United States - Yahoo Finance

Feb 24, 2025
pulisher
Feb 20, 2025

MannKind: Q2 Earnings Snapshot -August 07, 2024 at 08:09 am EDT - Marketscreener.com

Feb 20, 2025
pulisher
Feb 19, 2025

MannKind Corporation to Hold 2024 Fourth Quarter and Full Year Financial Results Conference Call on February 26, 2025 - Yahoo Finance

Feb 19, 2025
pulisher
Feb 19, 2025

MannKind Sets Stage for 2024 Performance Review: CEO and CFO to Unveil Full Year Results - Stock Titan

Feb 19, 2025
pulisher
Feb 18, 2025

MannKind (MNKD) Expected to Announce Earnings on Tuesday - MarketBeat

Feb 18, 2025
pulisher
Feb 13, 2025

Wedbush Initiates Coverage on MannKind (NASDAQ:MNKD) - MarketBeat

Feb 13, 2025
pulisher
Feb 11, 2025

MannKind To Present At Oppenheimer Healthcare Life Sciences Conference; Webcast At 11:20 AM ET - Nasdaq

Feb 11, 2025
pulisher
Feb 11, 2025

An Analysis of Mannkind Corp (MNKD)’s Potential Price Growth - Knox Daily

Feb 11, 2025
pulisher
Feb 11, 2025

MannKind (NASDAQ:MNKD) Coverage Initiated by Analysts at Wedbush - Defense World

Feb 11, 2025
pulisher
Feb 10, 2025

Investing in Fortuna Mining Corp (FSM) Is Getting More Attractive - Knox Daily

Feb 10, 2025
pulisher
Feb 09, 2025

MannKind Co. (NASDAQ:MNKD) Shares Sold by Calamos Advisors LLC - MarketBeat

Feb 09, 2025
pulisher
Feb 07, 2025

There is no doubt that Mannkind Corp (MNKD) ticks all the boxes. - SETE News

Feb 07, 2025
pulisher
Feb 06, 2025

MannKind to Present at Upcoming Investor Conferences - Yahoo Finance

Feb 06, 2025
pulisher
Feb 06, 2025

MNKD Shares Experience Surge in Value - Knox Daily

Feb 06, 2025
pulisher
Feb 06, 2025

MannKind Executives Set for Strategic Presentations at Elite Healthcare Investment Forums - StockTitan

Feb 06, 2025
pulisher
Feb 04, 2025

Financial Fitness Check: Examining Mannkind Corp (MNKD)’s Key Ratios - The Dwinnex

Feb 04, 2025
pulisher
Feb 03, 2025

(02/03/25) Top Picks 2025: MannKind (MNKD) - Moneyshow.com

Feb 03, 2025
pulisher
Feb 02, 2025

MannKind Corporation's (NASDAQ:MNKD) institutional investors lost 4.0% over the past week but have profited from longer-term gains - Yahoo Finance

Feb 02, 2025
$68.32
price up icon 0.62%
$73.44
price up icon 1.89%
$31.28
price up icon 0.40%
$20.46
price up icon 8.72%
$93.32
price up icon 3.33%
biotechnology ONC
$274.78
price up icon 1.41%
Kapitalisierung:     |  Volumen (24h):